RE:Volume AEZS NASDAQA big goal for investors is to get in before the crowd, fossi. I've said many times that we are early and before key and strategic milestones. The question is what happens if the key milestones are hit. What happens when AEZS's diagnostic data for the most important markets(children) is released? What happens if FDA and European approval to sell the test is given? What happens if AEZS signs a licensing deal(upfront, milestone payments, royalties)? What happens if PGX is successfully commissioned at 5X and 10X scale-up this year; including with Natex? What happens if a PGX licensing deal is signed upon successful scale-up? What happens when safety/tolerability, preliminary efficacy for the avenanthramide clinical trial is released? What happens if clinical trial 'go' decisions happen for fibrosis, wound healing, AIM Biologicals? What happens if licensing deals occur for the aveanthramide pill, wound healing program, and for AIM Biologicals? What happens if CZO's main client returns, the new powder formulations of avenanthramide and oat beta glucan are released, and sales of malted avenanthramide into the neutraceutical market begin? The merger puts in place capital to pursue CZO's plans for significant growth the news release says. There's a lot about to happen given the milestones lined up. Given the C$100 million target price for AEZS from H.C. Wainwright, and that it is a merger of equals it could be seen as a capital raise at $1.25 per share of CZO without warrants and with other benefits. That could sure beat a financng with warrants, etc. It is seen as the best path forward according to Ronnie Miller.
fossi_2002 wrote: Is this a market for investors? 17:47:51 | Q | 2.31 | 0.19 | 1 |
17:47:19 | Q | 2.09 | -0.03 | 1 |
16:15:38 | Q | 2.20 | 0.08 | 300 |
16:06:03 | Q | 2.33 | 0.21 | 10 |
16:02:24 | Q | 2.33 | 0.21 | 1 |
16:00:01 | Q | 2.05 | -0.07 | 2 |
15:59:52 | Q | 2.06 | -0.06 | 98 |
15:59:52 | Q | 2.05 | -0.07 | 2 |
15:59:51 | Q | 2.06 | -0.06 | 2 |
15:58:36 | Q | 2.08 | -0.04 | 100 |
Recent Trades - Last 10 of 93 | More trades... |